Combination therapy with liposomal doxorubicin and liposomal vaccine containing E75, an HER-2/neu-derived peptide, reduces myeloid-derived suppressor cells and improved tumor therapy

Zamani, P. and Navashenaq, J. G. and Teymouri, M. and Karimi, M. and Mashreghi, M. and Jaafari, M. R. (2020) Combination therapy with liposomal doxorubicin and liposomal vaccine containing E75, an HER-2/neu-derived peptide, reduces myeloid-derived suppressor cells and improved tumor therapy. Life Sciences, 252.

[img] Other (Article)
S0024320520303945_via=ihub

Download (76kB)
Item Type: Article
Additional Information: Export Date: 7 July 2020
Subjects: QV pharmacology
Divisions: Mashhad University of Medical Sciences
Depositing User: mr lib5 lib5
Date Deposited: 20 Jul 2020 09:07
Last Modified: 20 Jul 2020 09:07
URI: http://eprints.mums.ac.ir/id/eprint/22661

Actions (login required)

View Item View Item